|
CAND1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.40160000000356E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26489999996426E-06 |
| Normal-vs-Stage2 |
9.037500E-03 |
| Normal-vs-Stage3 |
2.162000E-01 |
| Normal-vs-Stage4 |
3.494800E-01 |
| Stage1-vs-Stage2 |
8.861000E-01 |
| Stage1-vs-Stage3 |
1.660200E-01 |
| Stage1-vs-Stage4 |
5.978800E-01 |
| Stage2-vs-Stage3 |
3.670600E-01 |
| Stage2-vs-Stage4 |
7.137800E-01 |
| Stage3-vs-Stage4 |
7.721400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.67020000000551E-05 |
| Normal-vs-AfricanAmerican |
1.704350E-02 |
| Normal-vs-Asian |
3.186800E-01 |
| Caucasian-vs-AfricanAmerican |
5.908600E-01 |
| Caucasian-vs-Asian |
9.388000E-01 |
| AfricanAmerican-vs-Asian |
9.119800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73750000054262E-07 |
| Normal-vs-Female |
8.361200E-01 |
| Male-vs-Female |
1.989100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.955900E-03 |
| Normal-vs-Extreme_Weight |
6.32300000136254E-08 |
| Normal-vs-Obese |
3.121700E-02 |
| Normal-vs-Extreme_Obese |
1.533710E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.728600E-01 |
| Normal_Weight-vs-Obese |
3.979200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.526600E-01 |
| Extreme_Weight-vs-Obese |
2.363700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.727000E-01 |
| Obese-vs-Extreme_Obese |
2.643800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.207000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.764500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.58679999995304E-06 |
| Normal-vs-Age(81-100Yrs) |
3.239600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.244030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.688020E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.006300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.652100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.420180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.070400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.13299999999306E-05 |
| Normal-VS-Type2 PRCC |
2.580000E-04 |
| Normal-VS-KIRP CIMP |
5.262400E-01 |
| Normal-VS-Unclassified PRCC |
3.775200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.744600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.947730E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.539400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.199800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.554600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.930200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.49749999997806E-06 |
| Normal-vs-N1 |
6.390600E-01 |
| Normal-vs-N2 |
7.946800E-01 |
| N0-vs-N1 |
2.043900E-02 |
| N0-vs-N2 |
1.010230E-01 |
| N1-vs-N2 |
9.113400E-01 |
|
|
